http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106350541-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-15043 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1793 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0066 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867 |
filingDate | 2016-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-106350541-B |
titleOfInvention | Construction method and application of congenital immunodeficiency gene therapy vector |
abstract | The invention relates to a recombinant lentiviral vector for expressing IL2RG gene and preparation thereof. The vector is a third generation lentivirus vector SIN which is inactivated by itself, and the sequence of the IL2RG gene is shown as SEQ ID NO: 1. The invention also provides a preparation method of the carrier and application of the carrier in preparing a medicament for treating primary immunodeficiency diseases. |
priorityDate | 2016-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 118.